51 results
Page 2 of 3
6-K
EX-99.2
4zjt z9qsb3bzlcpl90
16 May 23
Condensed Interim Consolidated Financial Statements
9:32am
6-K
EX-99.3
3rv5vc
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.2
a4ilqo
3 Apr 23
Consolidated Financial Statements
6:05am
6-K
EX-99.1
7xk1gi2hgfzpzcapw
16 Nov 22
XORTX Therapeutics Appoints Stacy Evans, M.D., MBA as Chief Business Officer
7:29am
424B3
fildhlaa6p
14 Nov 22
Prospectus supplement
1:51pm
6-K
EX-99.2
376jh a0b8
14 Nov 22
Condensed Interim Consolidated Financial Statements
1:04pm
424B4
9ijitenswilf1b g9
5 Oct 22
Prospectus supplement with pricing info
5:24pm
POS AM
07av0
29 Sep 22
Prospectus update (post-effective amendment)
9:49pm
F-1/A
0waavoluwwn
21 Sep 22
Registration statement (foreign) (amended)
4:20pm
F-1
bmrso05s0ra p0v
8 Sep 22
Registration statement (foreign)
1:02pm
DRS
59njtm
15 Aug 22
Draft registration statement
12:00am
6-K
EX-99.2
8rw6l3i
11 Aug 22
Condensed Interim Consolidated Financial Statements
7:00am
6-K
EX-99.1
f1qgmf7d9c
29 Jun 22
Current report (foreign)
9:58pm
6-K
EX-99.2
0kn19 s04m4
16 May 22
Condensed Interim Consolidated Financial Statements
7:25am
20-F
EX-15.1
j9w6o
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.20
9hy7skutq4mnazl5
3 May 22
Annual report (foreign)
5:29pm
20-F
6axo5aff
3 May 22
Annual report (foreign)
5:29pm
20-F
EX-4.27
r6r6k7koi
3 May 22
Annual report (foreign)
5:29pm